Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?

First-Trimester Prediction of Preeclampsia in Nulliparous Women at Low Risk

(2012) Leslie Myatt et al.   OBSTETRICS AND GYNECOLOGY

Combining Biochemical and Ultrasonographic Markers in Predicting Preeclampsia: A Systematic Review

(2010) Y. Giguere et al.   CLINICAL CHEMISTRY

Vitamins C and E to Prevent Complications of Pregnancy-Associated Hypertension

(2010) James M. Roberts et al.   NEW ENGLAND JOURNAL OF MEDICINE

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

(2009) Juan Pedro Kusanovic et al.   Journal of Maternal-Fetal & Neonatal Medicine

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age

(2008) Offer Erez et al.   Journal of Maternal-Fetal & Neonatal Medicine

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

(2008) Roberto Romero et al.   Journal of Maternal-Fetal & Neonatal Medicine

The Two Stage Model of Preeclampsia: Variations on the Theme

(2008) J.M. Roberts et al.   PLACENTA